Reliable Genotypic Tropism Tests for the Major HIV-1 Subtypes

Over the past decade antiretroviral drugs have dramatically improved the prognosis for HIV-1 infected individuals, yet achieving better access to vulnerable populations remains a challenge. The principal obstacle to the CCR5-antagonist, maraviroc, from being more widely used in anti-HIV-1 therapy re...

Descripción completa

Detalles Bibliográficos
Autores principales: Cashin, Kieran, Gray, Lachlan R., Harvey, Katherine L., Perez-Bercoff, Danielle, Lee, Guinevere Q., Sterjovski, Jasminka, Roche, Michael, Demarest, James F., Drummond, Fraser, Harrigan, P. Richard, Churchill, Melissa J., Gorry, Paul R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894445/
https://www.ncbi.nlm.nih.gov/pubmed/25712827
http://dx.doi.org/10.1038/srep08543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894445/
https://www.ncbi.nlm.nih.gov/pubmed/25712827
http://dx.doi.org/10.1038/srep08543

Ejemplares similares